These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32235255)

  • 1. Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
    Jackson KR; Long J; Motter J; Bowring MG; Chen J; Waldram MM; Orandi BJ; Montgomery RA; Stegall MD; Jordan SC; Benedetti E; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Verbesey JE; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Wellen J; Bozorgzadeh A; Gaber AO; Heher E; Weng FL; Djamali A; Helderman JH; Concepcion BP; Brayman KL; Oberholzer J; Kozlowski T; Covarrubias K; Desai N; Massie AB; Segev DL; Garonzik-Wang J
    Transplantation; 2021 Feb; 105(2):436-442. PubMed ID: 32235255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
    Malvezzi P; Jouve T; Noble J; Rostaing L
    Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration.
    Kimball PM; McDougan FA; King A
    Clin Transpl; 2014; ():197-203. PubMed ID: 26281145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney paired donation in the presence of donor-specific antibodies.
    Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
    Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
    Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients.
    Long JJ; Motter JD; Jackson KR; Chen J; Orandi BJ; Montgomery RA; Stegall MD; Jordan SC; Benedetti E; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Verbesey JE; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Wellen JR; Bozorgzadeh A; Gaber AO; Heher EC; Weng FL; Djamali A; Helderman JH; Concepcion BP; Brayman KL; Oberholzer J; Kozlowski T; Covarrubias K; Massie AB; McAdams-DeMarco MA; Segev DL; Garonzik-Wang JM
    Am J Transplant; 2023 Dec; 23(12):1980-1989. PubMed ID: 37748554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the risk of incompatible kidney transplantation: a multicenter study.
    Orandi BJ; Garonzik-Wang JM; Massie AB; Zachary AA; Montgomery JR; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
    Am J Transplant; 2014 Jul; 14(7):1573-80. PubMed ID: 24913913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
    Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
    Lee HS; Kim MS; Kim YS; Joo DJ; Ju MK; Kim SJ; Kim SI; Huh KH; Park K
    Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper.
    Crespo M; Zárraga S; Alonso Á; Beneyto I; Díaz Corte C; Fernandez Rodriguez AM; Franco A; Hernández D; González-Roncero FM; Jiménez Martín C; Jimeno L; Lauzurica Valdemoros LR; Llorente S; Mazuecos A; Osuna A; Ramos JP; Rodríguez Benot A; Ruiz San Millán JC; Sánchez Fructuoso A; Torregrosa JV; Guirado L;
    Transplantation; 2020 Aug; 104(8 Suppl 2):S1-S12. PubMed ID: 32658025
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes in Third and Fourth Kidney Transplants Based on the Type of Donor.
    Dabare D; Kassimatis T; Hodson J; Khurram MA; Papadakis G; Rompianesi G; Shaw O; Karydis N; Callaghan C; Olsburgh J; Mamode N; Kessaris N; Loukopoulos I
    Transplantation; 2019 Jul; 103(7):1494-1503. PubMed ID: 30130325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP
    Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA Class II Antibodies at the Time of Kidney Transplantation and Cardiovascular Outcome: A Retrospective Cohort Study.
    Malfait T; Emonds MP; Daniëls L; Nagler EV; Van Biesen W; Van Laecke S
    Transplantation; 2020 Apr; 104(4):823-834. PubMed ID: 31369517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA-matching effect in different cohorts of kidney transplant recipients: 10 years later.
    Sasaki N; Idica A
    Clin Transpl; 2010; ():261-82. PubMed ID: 21696046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.